Abstract
The on-going diversification of influenza virus necessicates annual vaccine updating. The vaccine antigen, the viral spike protein hemagglutinin (HA), tends to elicit strain-specific neutralizing activity, predicting that sequential immunization with the same HA strain will boost antibodies with narrow coverage. However, repeated vaccination with homologous SARS-CoV-2 vaccine eventually elicits neutralizing activity against highly unmatched variants, questioning this immunological premise. We evaluated a longitudinal influenza vaccine cohort, where each year the subjects received the same, novel H1N1 2009 pandemic vaccine strain. Repeated vaccination gradually enhanced receptor-blocking antibodies (HAI) to highly unmatched H1N1 strains within individuals with no initial memory recall against these historical viruses. An in silico model of affinity maturation in germinal centers integrated with a model of differentiation and expansion of memory cells provides insight into the mechanisms underlying these results and shows how repeated exposure to the same immunogen can broaden the antibody response against diversified targets.
Competing Interest Statement
DL reports SAB membership for Metaphore Bio (a Flagship company), Tendel Therapies, and Lattice Therapeutics Inc. AKC is a consultant of Flagship Pioneering, a consultant and member of the Strategic Oversight Board of Apriori Bio (a Flagship company), and a consultant and SAB member of Metaphore Bio.
Funding Statement
The authors acknowledge support form the NIH [U19AI057229; AI155447, AI137057, AI153098, AI146779, AI089618, AI060354; contracts 75N93019C00050 and 75N93019C00052.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Nunez, I.A., Carlock, M.A., Allen, J.D., Owino, S.O., Moehling, K.K., Nowak, P., Susick, M., Diagle, K., Sweeney, K., Mundle, S., et al. (2017). Impact of age and pre-existing influenza immune responses in humans receiving split inactivated influenza vaccine on the induction of the breadth of antibodies to influenza A strains. PloS one 12, e0185666. 10.1371/journal.pone.0185666. In this 2017 study, the study procedures, informed consent, and data collection documents were reviewed and approved by was approved by the Western Institutional Review Board and the Institutional Review Boards of the University of Pittsburgh and the University of Georgia. Informed written consent was obtained from the parents/guardians of the children
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon request to the authors. The raw data is also provided in Data S1.
